RIO DE JANEIRO - Brazil's health regulator Anvisa said on Friday it had suspended the production, sale and use of products made by Brazilian breast-implant maker Silimed after an inspection found the company failed production standards.
- Heart device maker St. Jude Medical Inc received a warning letter from the U.S. Food and Drug Administration, which said that various devices of the company manufactured at its Atlanta plant are adulterated.
(Reuters Health) - A therapeutic program of weight-bearing exercise reduces pain and improves joint function, at least for two to six months, for people with osteoarthritis, according to a review of previous trials.
(Reuters Health) - Although women make up roughly half of the world’s HIV cases, they remain largely excluded from clinical trials testing drugs, vaccines and potential cures for the virus, a research review confirms.
(Reuters Health) - Caring for a loved one with Alzheimer’s disease isn’t easy under the best of circumstances, but it may be much more stressful for spouses and people who suffer from depression, a Finnish study suggests.
- The U.S. Food and Drug Administration on Friday approved Merck & Co Inc's immunotherapy, Keytruda, for patients with the most common form of lung cancer whose tumors produce a specific biological marker.
(Reuters Health) - People with long-term exposure to loud noise at work or in leisure activities may be at increased risk of heart disease, a U.S. study finds.
(Reuters Health) - U.S. states need better policies for transporting high-risk pregnant women and newborns to the specialized care they need - and then back to their local hospitals for continuing care, researchers say.
- Amicus Therapeutics Inc said it was unlikely to submit a U.S. marketing application for its lead drug, to treat Fabry disease, by the end of 2015 as expected, after U.S. health regulators asked for a more comprehensive analysis of trial data.
ATHENS - Greek health authorities urged the public to take health precautions on Friday after a suspected cholera case was discovered on Kos island, a tourist destination and entry point for migrants from the Middle East and Asia.